Seethru Equity Updates GBSN Report Following Latest FDA Clearance Posted on July 18, 2017 in Featured, Investors Seethru Equity updated their report of Great Basin following the FDA clearance of the company’s Stool Bacterial Pathogens Panel. View Post View Link Share this:LinkedInFacebookTwitterGoogleEmailMorePrintRedditTumblrPocketPinterest
